Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia.
S Afr Med J
; 111(6): 535-537, 2021 04 20.
Article
em En
| MEDLINE
| ID: mdl-34382561
ABSTRACT
There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Contexto em Saúde:
4_TD
Problema de saúde:
4_pneumonia
Assunto principal:
Trombocitopenia
/
Trombose
/
Vacinas contra COVID-19
/
COVID-19
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Guideline
Limite:
Humans
País/Região como assunto:
Africa
Idioma:
En
Revista:
S Afr Med J
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
África do Sul